Sodium Zirconium Cyclosilicate (SZC)

A photo of Korbin and Dr Dean Wallace

Korbin and Dr Dean Wallace

Sodium Zirconium Cyclosilicate (SZC) trial for the correction of hyperkalaemia

A clinical trial of a medication in children with kidney disease that has been demonstrated to effectively control high potassium levels, or hyperkalaemia, in adult patients.

  • Study opened: 2019
  • Trial area: International
  • First patient recruited: February 2020
  • Principal Investigator: Dr Dean Walker

In the news